HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.

AuthorsM Luppi, R Trovato, P Barozzi, D Vallisa, G Rossi, A Re, L Ravazzini, L Potenza, G Riva, M Morselli, G Longo, L Cavanna, R Roncaglia, G Torelli
JournalLeukemia (Leukemia) Vol. 19 Issue 3 Pg. 473-6 (Mar 2005) ISSN: 0887-6924 [Print] England
PMID15674353 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Organophosphonates
  • Cytosine
  • Cidofovir
Topics
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents (administration & dosage, therapeutic use)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Cidofovir
  • Cytosine (administration & dosage, analogs & derivatives, therapeutic use)
  • Herpesvirus 8, Human (drug effects)
  • Humans
  • Injections, Intralesional
  • Lymphoma, B-Cell (drug therapy, virology)
  • Lymphoma, Non-Hodgkin (drug therapy, virology)
  • Male
  • Organophosphonates (administration & dosage, therapeutic use)
  • Remission Induction
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: